🔗 Share this article

An underground economy for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Followers are urged to message these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a flourishing market exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and claims of next-day UK delivery. Sellers market the drug there before directing buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Express Worries

However, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.

Several experts said the popularity for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, advertising, and consumer regulations, risking fines, prosecution or imprisonment.

Platform Response and Content Removal

According to the social media company, the platform has removed violative material and banned related hashtags and search suggestions. The company said it was committed to keeping the service secure and allocating resources in strengthening compliance measures.

Online Trading Operations

Research also discovered groups with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, filled with photos of weight loss, glowing testimonials and detailed instructions for preparing or injecting at residence.

After moments of joining one group, a seller shared WhatsApp details, where the majority of transactions occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, health issues or past usage.

Product Information and Pricing

Within these groups, messages show black plastic parcels with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When questioned how much time a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for Telegram said it actively moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they can’t verify. Even if the science behind this drug is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has already encountered patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may expose patients to possibly significant health risks”.